Biden Administration Again Delays Action on Menthol Cigarette Ban | Healthiest Communities | U.S. News
U.S. News & World Report -

The Biden administration said Friday more time is needed to weigh a potential menthol cigarette ban, dealing a blow to public health advocates with another delay while citing “an immense amount of feedback” generated by the proposal.The news comes ahead of November’s hotly contested presidential election and amid concerns that a long-anticipated menthol ban could harm President Joe Biden’s support among Black voters, with menthol cigarettes disproportionately used by the Black community in the...

In related news

  • Biden administration delays plan to ban menthol cigarettes again

    Top health official gives no timeline for issuing rule, saying administration taking more time to consider feedbackFor the second time in recent months, the Joe Biden White House has delayed a sweeping plan to ban menthol cigarettes, a decision that is certain to infuriate anti-smoking advocates but could avoid angering Black voters ahead of November elections.In a statement on Friday, the president’s top health official gave no timeline for issuing the rule, saying only that the administration...

  • Biden administration delays plans to ban menthol cigarettes

    The Biden Administration has delayed plans to ban menthol cigarettes, a proposal announced by the Food and Drug Administration years ago. "There are still more conversations to have, and that will take significantly more time," Department of Health and Human Services Secretary Xavier Becerra said in a statement Friday. The FDA announced its plans to ban menthol tobacco cigarettes in 2021, followed by its proposed rules for the ban in 2022. The move was aimed to improve the health of those most...

  • Biden administration delays proposed ban on menthol cigarettes

    A proposed ban on menthol cigarettes in the US “will take significantly more time,” US Health and Human Services Secretary Xavier Becerra said in a statement Friday. A coalition of civil rights and medical organizations sued the US Food and Drug Administration this month for missing its own deadline to take action on the long-awaited rule. An administration official declined to specify further what the current timeline for a final decision might be, saying there was a need to speak with more...